--- title: "Top 10 HK Stock Gainers (2.6)" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/275095876.md" description: "BAO PHARMA-B(02659) rose 13.15%, with a trading turnover 111.1 Million HKD, and a year-to-date rose 43.1%. REALORD GROUP(01196) rose 11.03%, with a trading turnover 219.8 Million HKD, and a year-to-date rose 30.6%. ASCLETIS-B(01672) rose 10.55%, with a trading turnover 116.2 Million HKD, and a year-to-date rose 33.5%." datetime: "2026-02-06T08:30:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275095876.md) - [en](https://longbridge.com/en/news/275095876.md) - [zh-HK](https://longbridge.com/zh-HK/news/275095876.md) --- > 支持的语言: [English](https://longbridge.com/en/news/275095876.md) | [繁體中文](https://longbridge.com/zh-HK/news/275095876.md) # Top 10 HK Stock Gainers (2.6) Hang Seng Index has fell 1.21%, with a year-to-date rose 3.6%; Hang Seng TECH Index has fell 1.11%, with a year-to-date fell 3.1%. BAO PHARMA-B(02659) rose 13.15%, with a trading turnover 111.1 Million HKD, and a year-to-date rose 43.1%. REALORD GROUP(01196) rose 11.03%, with a trading turnover 219.8 Million HKD, and a year-to-date rose 30.6%. ASCLETIS-B(01672) rose 10.55%, with a trading turnover 116.2 Million HKD, and a year-to-date rose 33.5%. ### 相关股票 - [BAO PHARMA-B (02659.HK)](https://longbridge.com/zh-CN/quote/02659.HK.md) - [REALORD GROUP (01196.HK)](https://longbridge.com/zh-CN/quote/01196.HK.md) - [ASCLETIS-B (01672.HK)](https://longbridge.com/zh-CN/quote/01672.HK.md) - [NUOBIKAN (02635.HK)](https://longbridge.com/zh-CN/quote/02635.HK.md) - [ALLIED GROUP (00373.HK)](https://longbridge.com/zh-CN/quote/00373.HK.md) - [APAC RESOURCES (01104.HK)](https://longbridge.com/zh-CN/quote/01104.HK.md) - [INNOCARE (09969.HK)](https://longbridge.com/zh-CN/quote/09969.HK.md) - [EDDING GENOR (06998.HK)](https://longbridge.com/zh-CN/quote/06998.HK.md) - [UNITEDENERGY GP (00467.HK)](https://longbridge.com/zh-CN/quote/00467.HK.md) - [NIO-SW (09866.HK)](https://longbridge.com/zh-CN/quote/09866.HK.md) ## 相关资讯与研究 - [Nuobikan Establishes Smart Airport Subsidiary and Secures Strategic Investment](https://longbridge.com/zh-CN/news/279672082.md) - [Allied Group Forecasts Turnaround to 2025 Profit](https://longbridge.com/zh-CN/news/279237656.md) - [Bao Pharmaceuticals Receives Chinese Regulatory Nod to Begin Trials of KJ101 in New Indication; Shares Up 6%](https://longbridge.com/zh-CN/news/278820212.md) - [Nuobikan AI sets March 30 board meeting to approve 2025 annual results](https://longbridge.com/zh-CN/news/279229744.md) - [Nio to deliver 80,000th 3rd-gen ES8 SUV this week](https://longbridge.com/zh-CN/news/279260192.md)